All lobbying filings

CAPITOL COUNSEL LLC

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) · Represent organizations that promote research and support growth of biotechnology industry

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 18, 2026

Official filing document

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 5

Medicare/Medicaid

Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21

Taxation/Internal Revenue Code

Legislative and regulatory issues affecting innovation, including vaccines.

Trade (domestic/foreign)

Issues related to tariffs.

Budget/Appropriations

Items related to USDA, FDA, genetic engineering, and regulations associated with biotechnology in the Agriculture/Rural Development/Food and Drug Administration proposed Appropriation measures for FY 2027 (House/Senate).

Health Issues

Public health issues impacting patient access to treatments. Updates and reforms to regulation of treatment development and research.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.